Global Hormonal Transdermal Patches Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Page: 107

Published Date: 09 Jan 2023

Category: Medical Devices & Consumables

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global Hormonal Transdermal Patches market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Hormonal Transdermal Patches market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Hormonal Transdermal Patches market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Hormonal Transdermal Patches market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Hormonal Transdermal Patches market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Hormonal Transdermal Patches market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Hormonal Transdermal Patches
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Hormonal Transdermal Patches market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Xulane, Twirla, Planned Parenthood, Lvye Pharma and Novartis, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation
Hormonal Transdermal Patches market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Contraceptive Patches
    Estradiol Patches
    Others

Market segment by Application
    Hospital
    Clinic

Major players covered
    Xulane
    Twirla
    Planned Parenthood
    Lvye Pharma
    Novartis
    Bayer Healthcare Pharmaceuticals
    Watson Labs
    Women First Healthcare Inc
    Noven
    AbbVie
    Lumara Health
    ANI Pharmaceuticals

Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Hormonal Transdermal Patches product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Hormonal Transdermal Patches, with price, sales, revenue and global market share of Hormonal Transdermal Patches from 2018 to 2023.
Chapter 3, the Hormonal Transdermal Patches competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Hormonal Transdermal Patches breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Hormonal Transdermal Patches market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Hormonal Transdermal Patches.
Chapter 14 and 15, to describe Hormonal Transdermal Patches sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Hormonal Transdermal Patches
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Hormonal Transdermal Patches Consumption Value by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Contraceptive Patches
        1.3.3 Estradiol Patches
        1.3.4 Others
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Hormonal Transdermal Patches Consumption Value by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Hospital
        1.4.3 Clinic
    1.5 Global Hormonal Transdermal Patches Market Size & Forecast
        1.5.1 Global Hormonal Transdermal Patches Consumption Value (2018 & 2022 & 2029)
        1.5.2 Global Hormonal Transdermal Patches Sales Quantity (2018-2029)
        1.5.3 Global Hormonal Transdermal Patches Average Price (2018-2029)

2 Manufacturers Profiles
    2.1 Xulane
        2.1.1 Xulane Details
        2.1.2 Xulane Major Business
        2.1.3 Xulane Hormonal Transdermal Patches Product and Services
        2.1.4 Xulane Hormonal Transdermal Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Xulane Recent Developments/Updates
    2.2 Twirla
        2.2.1 Twirla Details
        2.2.2 Twirla Major Business
        2.2.3 Twirla Hormonal Transdermal Patches Product and Services
        2.2.4 Twirla Hormonal Transdermal Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Twirla Recent Developments/Updates
    2.3 Planned Parenthood
        2.3.1 Planned Parenthood Details
        2.3.2 Planned Parenthood Major Business
        2.3.3 Planned Parenthood Hormonal Transdermal Patches Product and Services
        2.3.4 Planned Parenthood Hormonal Transdermal Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Planned Parenthood Recent Developments/Updates
    2.4 Lvye Pharma
        2.4.1 Lvye Pharma Details
        2.4.2 Lvye Pharma Major Business
        2.4.3 Lvye Pharma Hormonal Transdermal Patches Product and Services
        2.4.4 Lvye Pharma Hormonal Transdermal Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Lvye Pharma Recent Developments/Updates
    2.5 Novartis
        2.5.1 Novartis Details
        2.5.2 Novartis Major Business
        2.5.3 Novartis Hormonal Transdermal Patches Product and Services
        2.5.4 Novartis Hormonal Transdermal Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Novartis Recent Developments/Updates
    2.6 Bayer Healthcare Pharmaceuticals
        2.6.1 Bayer Healthcare Pharmaceuticals Details
        2.6.2 Bayer Healthcare Pharmaceuticals Major Business
        2.6.3 Bayer Healthcare Pharmaceuticals Hormonal Transdermal Patches Product and Services
        2.6.4 Bayer Healthcare Pharmaceuticals Hormonal Transdermal Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Bayer Healthcare Pharmaceuticals Recent Developments/Updates
    2.7 Watson Labs
        2.7.1 Watson Labs Details
        2.7.2 Watson Labs Major Business
        2.7.3 Watson Labs Hormonal Transdermal Patches Product and Services
        2.7.4 Watson Labs Hormonal Transdermal Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Watson Labs Recent Developments/Updates
    2.8 Women First Healthcare Inc
        2.8.1 Women First Healthcare Inc Details
        2.8.2 Women First Healthcare Inc Major Business
        2.8.3 Women First Healthcare Inc Hormonal Transdermal Patches Product and Services
        2.8.4 Women First Healthcare Inc Hormonal Transdermal Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Women First Healthcare Inc Recent Developments/Updates
    2.9 Noven
        2.9.1 Noven Details
        2.9.2 Noven Major Business
        2.9.3 Noven Hormonal Transdermal Patches Product and Services
        2.9.4 Noven Hormonal Transdermal Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Noven Recent Developments/Updates
    2.10 AbbVie
        2.10.1 AbbVie Details
        2.10.2 AbbVie Major Business
        2.10.3 AbbVie Hormonal Transdermal Patches Product and Services
        2.10.4 AbbVie Hormonal Transdermal Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 AbbVie Recent Developments/Updates
    2.11 Lumara Health
        2.11.1 Lumara Health Details
        2.11.2 Lumara Health Major Business
        2.11.3 Lumara Health Hormonal Transdermal Patches Product and Services
        2.11.4 Lumara Health Hormonal Transdermal Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.11.5 Lumara Health Recent Developments/Updates
    2.12 ANI Pharmaceuticals
        2.12.1 ANI Pharmaceuticals Details
        2.12.2 ANI Pharmaceuticals Major Business
        2.12.3 ANI Pharmaceuticals Hormonal Transdermal Patches Product and Services
        2.12.4 ANI Pharmaceuticals Hormonal Transdermal Patches Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
        2.12.5 ANI Pharmaceuticals Recent Developments/Updates

3 Competitive Environment: Hormonal Transdermal Patches by Manufacturer
    3.1 Global Hormonal Transdermal Patches Sales Quantity by Manufacturer (2018-2023)
    3.2 Global Hormonal Transdermal Patches Revenue by Manufacturer (2018-2023)
    3.3 Global Hormonal Transdermal Patches Average Price by Manufacturer (2018-2023)
    3.4 Market Share Analysis (2022)
        3.4.1 Producer Shipments of Hormonal Transdermal Patches by Manufacturer Revenue ($MM) and Market Share (%): 2022
        3.4.2 Top 3 Hormonal Transdermal Patches Manufacturer Market Share in 2022
        3.4.2 Top 6 Hormonal Transdermal Patches Manufacturer Market Share in 2022
    3.5 Hormonal Transdermal Patches Market: Overall Company Footprint Analysis
        3.5.1 Hormonal Transdermal Patches Market: Region Footprint
        3.5.2 Hormonal Transdermal Patches Market: Company Product Type Footprint
        3.5.3 Hormonal Transdermal Patches Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Hormonal Transdermal Patches Market Size by Region
        4.1.1 Global Hormonal Transdermal Patches Sales Quantity by Region (2018-2029)
        4.1.2 Global Hormonal Transdermal Patches Consumption Value by Region (2018-2029)
        4.1.3 Global Hormonal Transdermal Patches Average Price by Region (2018-2029)
    4.2 North America Hormonal Transdermal Patches Consumption Value (2018-2029)
    4.3 Europe Hormonal Transdermal Patches Consumption Value (2018-2029)
    4.4 Asia-Pacific Hormonal Transdermal Patches Consumption Value (2018-2029)
    4.5 South America Hormonal Transdermal Patches Consumption Value (2018-2029)
    4.6 Middle East and Africa Hormonal Transdermal Patches Consumption Value (2018-2029)

5 Market Segment by Type
    5.1 Global Hormonal Transdermal Patches Sales Quantity by Type (2018-2029)
    5.2 Global Hormonal Transdermal Patches Consumption Value by Type (2018-2029)
    5.3 Global Hormonal Transdermal Patches Average Price by Type (2018-2029)

6 Market Segment by Application
    6.1 Global Hormonal Transdermal Patches Sales Quantity by Application (2018-2029)
    6.2 Global Hormonal Transdermal Patches Consumption Value by Application (2018-2029)
    6.3 Global Hormonal Transdermal Patches Average Price by Application (2018-2029)

7 North America
    7.1 North America Hormonal Transdermal Patches Sales Quantity by Type (2018-2029)
    7.2 North America Hormonal Transdermal Patches Sales Quantity by Application (2018-2029)
    7.3 North America Hormonal Transdermal Patches Market Size by Country
        7.3.1 North America Hormonal Transdermal Patches Sales Quantity by Country (2018-2029)
        7.3.2 North America Hormonal Transdermal Patches Consumption Value by Country (2018-2029)
        7.3.3 United States Market Size and Forecast (2018-2029)
        7.3.4 Canada Market Size and Forecast (2018-2029)
        7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe
    8.1 Europe Hormonal Transdermal Patches Sales Quantity by Type (2018-2029)
    8.2 Europe Hormonal Transdermal Patches Sales Quantity by Application (2018-2029)
    8.3 Europe Hormonal Transdermal Patches Market Size by Country
        8.3.1 Europe Hormonal Transdermal Patches Sales Quantity by Country (2018-2029)
        8.3.2 Europe Hormonal Transdermal Patches Consumption Value by Country (2018-2029)
        8.3.3 Germany Market Size and Forecast (2018-2029)
        8.3.4 France Market Size and Forecast (2018-2029)
        8.3.5 United Kingdom Market Size and Forecast (2018-2029)
        8.3.6 Russia Market Size and Forecast (2018-2029)
        8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific
    9.1 Asia-Pacific Hormonal Transdermal Patches Sales Quantity by Type (2018-2029)
    9.2 Asia-Pacific Hormonal Transdermal Patches Sales Quantity by Application (2018-2029)
    9.3 Asia-Pacific Hormonal Transdermal Patches Market Size by Region
        9.3.1 Asia-Pacific Hormonal Transdermal Patches Sales Quantity by Region (2018-2029)
        9.3.2 Asia-Pacific Hormonal Transdermal Patches Consumption Value by Region (2018-2029)
        9.3.3 China Market Size and Forecast (2018-2029)
        9.3.4 Japan Market Size and Forecast (2018-2029)
        9.3.5 Korea Market Size and Forecast (2018-2029)
        9.3.6 India Market Size and Forecast (2018-2029)
        9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
        9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America
    10.1 South America Hormonal Transdermal Patches Sales Quantity by Type (2018-2029)
    10.2 South America Hormonal Transdermal Patches Sales Quantity by Application (2018-2029)
    10.3 South America Hormonal Transdermal Patches Market Size by Country
        10.3.1 South America Hormonal Transdermal Patches Sales Quantity by Country (2018-2029)
        10.3.2 South America Hormonal Transdermal Patches Consumption Value by Country (2018-2029)
        10.3.3 Brazil Market Size and Forecast (2018-2029)
        10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa
    11.1 Middle East & Africa Hormonal Transdermal Patches Sales Quantity by Type (2018-2029)
    11.2 Middle East & Africa Hormonal Transdermal Patches Sales Quantity by Application (2018-2029)
    11.3 Middle East & Africa Hormonal Transdermal Patches Market Size by Country
        11.3.1 Middle East & Africa Hormonal Transdermal Patches Sales Quantity by Country (2018-2029)
        11.3.2 Middle East & Africa Hormonal Transdermal Patches Consumption Value by Country (2018-2029)
        11.3.3 Turkey Market Size and Forecast (2018-2029)
        11.3.4 Egypt Market Size and Forecast (2018-2029)
        11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
        11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics
    12.1 Hormonal Transdermal Patches Market Drivers
    12.2 Hormonal Transdermal Patches Market Restraints
    12.3 Hormonal Transdermal Patches Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry
    12.5 Influence of COVID-19 and Russia-Ukraine War
        12.5.1 Influence of COVID-19
        12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain
    13.1 Raw Material of Hormonal Transdermal Patches and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Hormonal Transdermal Patches
    13.3 Hormonal Transdermal Patches Production Process
    13.4 Hormonal Transdermal Patches Industrial Chain

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Hormonal Transdermal Patches Typical Distributors
    14.3 Hormonal Transdermal Patches Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Hormonal Transdermal Patches Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Hormonal Transdermal Patches Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Xulane Basic Information, Manufacturing Base and Competitors
    Table 4. Xulane Major Business
    Table 5. Xulane Hormonal Transdermal Patches Product and Services
    Table 6. Xulane Hormonal Transdermal Patches Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 7. Xulane Recent Developments/Updates
    Table 8. Twirla Basic Information, Manufacturing Base and Competitors
    Table 9. Twirla Major Business
    Table 10. Twirla Hormonal Transdermal Patches Product and Services
    Table 11. Twirla Hormonal Transdermal Patches Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 12. Twirla Recent Developments/Updates
    Table 13. Planned Parenthood Basic Information, Manufacturing Base and Competitors
    Table 14. Planned Parenthood Major Business
    Table 15. Planned Parenthood Hormonal Transdermal Patches Product and Services
    Table 16. Planned Parenthood Hormonal Transdermal Patches Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 17. Planned Parenthood Recent Developments/Updates
    Table 18. Lvye Pharma Basic Information, Manufacturing Base and Competitors
    Table 19. Lvye Pharma Major Business
    Table 20. Lvye Pharma Hormonal Transdermal Patches Product and Services
    Table 21. Lvye Pharma Hormonal Transdermal Patches Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 22. Lvye Pharma Recent Developments/Updates
    Table 23. Novartis Basic Information, Manufacturing Base and Competitors
    Table 24. Novartis Major Business
    Table 25. Novartis Hormonal Transdermal Patches Product and Services
    Table 26. Novartis Hormonal Transdermal Patches Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 27. Novartis Recent Developments/Updates
    Table 28. Bayer Healthcare Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 29. Bayer Healthcare Pharmaceuticals Major Business
    Table 30. Bayer Healthcare Pharmaceuticals Hormonal Transdermal Patches Product and Services
    Table 31. Bayer Healthcare Pharmaceuticals Hormonal Transdermal Patches Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 32. Bayer Healthcare Pharmaceuticals Recent Developments/Updates
    Table 33. Watson Labs Basic Information, Manufacturing Base and Competitors
    Table 34. Watson Labs Major Business
    Table 35. Watson Labs Hormonal Transdermal Patches Product and Services
    Table 36. Watson Labs Hormonal Transdermal Patches Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 37. Watson Labs Recent Developments/Updates
    Table 38. Women First Healthcare Inc Basic Information, Manufacturing Base and Competitors
    Table 39. Women First Healthcare Inc Major Business
    Table 40. Women First Healthcare Inc Hormonal Transdermal Patches Product and Services
    Table 41. Women First Healthcare Inc Hormonal Transdermal Patches Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 42. Women First Healthcare Inc Recent Developments/Updates
    Table 43. Noven Basic Information, Manufacturing Base and Competitors
    Table 44. Noven Major Business
    Table 45. Noven Hormonal Transdermal Patches Product and Services
    Table 46. Noven Hormonal Transdermal Patches Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 47. Noven Recent Developments/Updates
    Table 48. AbbVie Basic Information, Manufacturing Base and Competitors
    Table 49. AbbVie Major Business
    Table 50. AbbVie Hormonal Transdermal Patches Product and Services
    Table 51. AbbVie Hormonal Transdermal Patches Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 52. AbbVie Recent Developments/Updates
    Table 53. Lumara Health Basic Information, Manufacturing Base and Competitors
    Table 54. Lumara Health Major Business
    Table 55. Lumara Health Hormonal Transdermal Patches Product and Services
    Table 56. Lumara Health Hormonal Transdermal Patches Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 57. Lumara Health Recent Developments/Updates
    Table 58. ANI Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 59. ANI Pharmaceuticals Major Business
    Table 60. ANI Pharmaceuticals Hormonal Transdermal Patches Product and Services
    Table 61. ANI Pharmaceuticals Hormonal Transdermal Patches Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 62. ANI Pharmaceuticals Recent Developments/Updates
    Table 63. Global Hormonal Transdermal Patches Sales Quantity by Manufacturer (2018-2023) & (K Units)
    Table 64. Global Hormonal Transdermal Patches Revenue by Manufacturer (2018-2023) & (USD Million)
    Table 65. Global Hormonal Transdermal Patches Average Price by Manufacturer (2018-2023) & (US$/Unit)
    Table 66. Market Position of Manufacturers in Hormonal Transdermal Patches, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
    Table 67. Head Office and Hormonal Transdermal Patches Production Site of Key Manufacturer
    Table 68. Hormonal Transdermal Patches Market: Company Product Type Footprint
    Table 69. Hormonal Transdermal Patches Market: Company Product Application Footprint
    Table 70. Hormonal Transdermal Patches New Market Entrants and Barriers to Market Entry
    Table 71. Hormonal Transdermal Patches Mergers, Acquisition, Agreements, and Collaborations
    Table 72. Global Hormonal Transdermal Patches Sales Quantity by Region (2018-2023) & (K Units)
    Table 73. Global Hormonal Transdermal Patches Sales Quantity by Region (2024-2029) & (K Units)
    Table 74. Global Hormonal Transdermal Patches Consumption Value by Region (2018-2023) & (USD Million)
    Table 75. Global Hormonal Transdermal Patches Consumption Value by Region (2024-2029) & (USD Million)
    Table 76. Global Hormonal Transdermal Patches Average Price by Region (2018-2023) & (US$/Unit)
    Table 77. Global Hormonal Transdermal Patches Average Price by Region (2024-2029) & (US$/Unit)
    Table 78. Global Hormonal Transdermal Patches Sales Quantity by Type (2018-2023) & (K Units)
    Table 79. Global Hormonal Transdermal Patches Sales Quantity by Type (2024-2029) & (K Units)
    Table 80. Global Hormonal Transdermal Patches Consumption Value by Type (2018-2023) & (USD Million)
    Table 81. Global Hormonal Transdermal Patches Consumption Value by Type (2024-2029) & (USD Million)
    Table 82. Global Hormonal Transdermal Patches Average Price by Type (2018-2023) & (US$/Unit)
    Table 83. Global Hormonal Transdermal Patches Average Price by Type (2024-2029) & (US$/Unit)
    Table 84. Global Hormonal Transdermal Patches Sales Quantity by Application (2018-2023) & (K Units)
    Table 85. Global Hormonal Transdermal Patches Sales Quantity by Application (2024-2029) & (K Units)
    Table 86. Global Hormonal Transdermal Patches Consumption Value by Application (2018-2023) & (USD Million)
    Table 87. Global Hormonal Transdermal Patches Consumption Value by Application (2024-2029) & (USD Million)
    Table 88. Global Hormonal Transdermal Patches Average Price by Application (2018-2023) & (US$/Unit)
    Table 89. Global Hormonal Transdermal Patches Average Price by Application (2024-2029) & (US$/Unit)
    Table 90. North America Hormonal Transdermal Patches Sales Quantity by Type (2018-2023) & (K Units)
    Table 91. North America Hormonal Transdermal Patches Sales Quantity by Type (2024-2029) & (K Units)
    Table 92. North America Hormonal Transdermal Patches Sales Quantity by Application (2018-2023) & (K Units)
    Table 93. North America Hormonal Transdermal Patches Sales Quantity by Application (2024-2029) & (K Units)
    Table 94. North America Hormonal Transdermal Patches Sales Quantity by Country (2018-2023) & (K Units)
    Table 95. North America Hormonal Transdermal Patches Sales Quantity by Country (2024-2029) & (K Units)
    Table 96. North America Hormonal Transdermal Patches Consumption Value by Country (2018-2023) & (USD Million)
    Table 97. North America Hormonal Transdermal Patches Consumption Value by Country (2024-2029) & (USD Million)
    Table 98. Europe Hormonal Transdermal Patches Sales Quantity by Type (2018-2023) & (K Units)
    Table 99. Europe Hormonal Transdermal Patches Sales Quantity by Type (2024-2029) & (K Units)
    Table 100. Europe Hormonal Transdermal Patches Sales Quantity by Application (2018-2023) & (K Units)
    Table 101. Europe Hormonal Transdermal Patches Sales Quantity by Application (2024-2029) & (K Units)
    Table 102. Europe Hormonal Transdermal Patches Sales Quantity by Country (2018-2023) & (K Units)
    Table 103. Europe Hormonal Transdermal Patches Sales Quantity by Country (2024-2029) & (K Units)
    Table 104. Europe Hormonal Transdermal Patches Consumption Value by Country (2018-2023) & (USD Million)
    Table 105. Europe Hormonal Transdermal Patches Consumption Value by Country (2024-2029) & (USD Million)
    Table 106. Asia-Pacific Hormonal Transdermal Patches Sales Quantity by Type (2018-2023) & (K Units)
    Table 107. Asia-Pacific Hormonal Transdermal Patches Sales Quantity by Type (2024-2029) & (K Units)
    Table 108. Asia-Pacific Hormonal Transdermal Patches Sales Quantity by Application (2018-2023) & (K Units)
    Table 109. Asia-Pacific Hormonal Transdermal Patches Sales Quantity by Application (2024-2029) & (K Units)
    Table 110. Asia-Pacific Hormonal Transdermal Patches Sales Quantity by Region (2018-2023) & (K Units)
    Table 111. Asia-Pacific Hormonal Transdermal Patches Sales Quantity by Region (2024-2029) & (K Units)
    Table 112. Asia-Pacific Hormonal Transdermal Patches Consumption Value by Region (2018-2023) & (USD Million)
    Table 113. Asia-Pacific Hormonal Transdermal Patches Consumption Value by Region (2024-2029) & (USD Million)
    Table 114. South America Hormonal Transdermal Patches Sales Quantity by Type (2018-2023) & (K Units)
    Table 115. South America Hormonal Transdermal Patches Sales Quantity by Type (2024-2029) & (K Units)
    Table 116. South America Hormonal Transdermal Patches Sales Quantity by Application (2018-2023) & (K Units)
    Table 117. South America Hormonal Transdermal Patches Sales Quantity by Application (2024-2029) & (K Units)
    Table 118. South America Hormonal Transdermal Patches Sales Quantity by Country (2018-2023) & (K Units)
    Table 119. South America Hormonal Transdermal Patches Sales Quantity by Country (2024-2029) & (K Units)
    Table 120. South America Hormonal Transdermal Patches Consumption Value by Country (2018-2023) & (USD Million)
    Table 121. South America Hormonal Transdermal Patches Consumption Value by Country (2024-2029) & (USD Million)
    Table 122. Middle East & Africa Hormonal Transdermal Patches Sales Quantity by Type (2018-2023) & (K Units)
    Table 123. Middle East & Africa Hormonal Transdermal Patches Sales Quantity by Type (2024-2029) & (K Units)
    Table 124. Middle East & Africa Hormonal Transdermal Patches Sales Quantity by Application (2018-2023) & (K Units)
    Table 125. Middle East & Africa Hormonal Transdermal Patches Sales Quantity by Application (2024-2029) & (K Units)
    Table 126. Middle East & Africa Hormonal Transdermal Patches Sales Quantity by Region (2018-2023) & (K Units)
    Table 127. Middle East & Africa Hormonal Transdermal Patches Sales Quantity by Region (2024-2029) & (K Units)
    Table 128. Middle East & Africa Hormonal Transdermal Patches Consumption Value by Region (2018-2023) & (USD Million)
    Table 129. Middle East & Africa Hormonal Transdermal Patches Consumption Value by Region (2024-2029) & (USD Million)
    Table 130. Hormonal Transdermal Patches Raw Material
    Table 131. Key Manufacturers of Hormonal Transdermal Patches Raw Materials
    Table 132. Hormonal Transdermal Patches Typical Distributors
    Table 133. Hormonal Transdermal Patches Typical Customers
List of Figures
    Figure 1. Hormonal Transdermal Patches Picture
    Figure 2. Global Hormonal Transdermal Patches Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Hormonal Transdermal Patches Consumption Value Market Share by Type in 2022
    Figure 4. Contraceptive Patches Examples
    Figure 5. Estradiol Patches Examples
    Figure 6. Others Examples
    Figure 7. Global Hormonal Transdermal Patches Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 8. Global Hormonal Transdermal Patches Consumption Value Market Share by Application in 2022
    Figure 9. Hospital Examples
    Figure 10. Clinic Examples
    Figure 11. Global Hormonal Transdermal Patches Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 12. Global Hormonal Transdermal Patches Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 13. Global Hormonal Transdermal Patches Sales Quantity (2018-2029) & (K Units)
    Figure 14. Global Hormonal Transdermal Patches Average Price (2018-2029) & (US$/Unit)
    Figure 15. Global Hormonal Transdermal Patches Sales Quantity Market Share by Manufacturer in 2022
    Figure 16. Global Hormonal Transdermal Patches Consumption Value Market Share by Manufacturer in 2022
    Figure 17. Producer Shipments of Hormonal Transdermal Patches by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
    Figure 18. Top 3 Hormonal Transdermal Patches Manufacturer (Consumption Value) Market Share in 2022
    Figure 19. Top 6 Hormonal Transdermal Patches Manufacturer (Consumption Value) Market Share in 2022
    Figure 20. Global Hormonal Transdermal Patches Sales Quantity Market Share by Region (2018-2029)
    Figure 21. Global Hormonal Transdermal Patches Consumption Value Market Share by Region (2018-2029)
    Figure 22. North America Hormonal Transdermal Patches Consumption Value (2018-2029) & (USD Million)
    Figure 23. Europe Hormonal Transdermal Patches Consumption Value (2018-2029) & (USD Million)
    Figure 24. Asia-Pacific Hormonal Transdermal Patches Consumption Value (2018-2029) & (USD Million)
    Figure 25. South America Hormonal Transdermal Patches Consumption Value (2018-2029) & (USD Million)
    Figure 26. Middle East & Africa Hormonal Transdermal Patches Consumption Value (2018-2029) & (USD Million)
    Figure 27. Global Hormonal Transdermal Patches Sales Quantity Market Share by Type (2018-2029)
    Figure 28. Global Hormonal Transdermal Patches Consumption Value Market Share by Type (2018-2029)
    Figure 29. Global Hormonal Transdermal Patches Average Price by Type (2018-2029) & (US$/Unit)
    Figure 30. Global Hormonal Transdermal Patches Sales Quantity Market Share by Application (2018-2029)
    Figure 31. Global Hormonal Transdermal Patches Consumption Value Market Share by Application (2018-2029)
    Figure 32. Global Hormonal Transdermal Patches Average Price by Application (2018-2029) & (US$/Unit)
    Figure 33. North America Hormonal Transdermal Patches Sales Quantity Market Share by Type (2018-2029)
    Figure 34. North America Hormonal Transdermal Patches Sales Quantity Market Share by Application (2018-2029)
    Figure 35. North America Hormonal Transdermal Patches Sales Quantity Market Share by Country (2018-2029)
    Figure 36. North America Hormonal Transdermal Patches Consumption Value Market Share by Country (2018-2029)
    Figure 37. United States Hormonal Transdermal Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 38. Canada Hormonal Transdermal Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 39. Mexico Hormonal Transdermal Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 40. Europe Hormonal Transdermal Patches Sales Quantity Market Share by Type (2018-2029)
    Figure 41. Europe Hormonal Transdermal Patches Sales Quantity Market Share by Application (2018-2029)
    Figure 42. Europe Hormonal Transdermal Patches Sales Quantity Market Share by Country (2018-2029)
    Figure 43. Europe Hormonal Transdermal Patches Consumption Value Market Share by Country (2018-2029)
    Figure 44. Germany Hormonal Transdermal Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 45. France Hormonal Transdermal Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 46. United Kingdom Hormonal Transdermal Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 47. Russia Hormonal Transdermal Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 48. Italy Hormonal Transdermal Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 49. Asia-Pacific Hormonal Transdermal Patches Sales Quantity Market Share by Type (2018-2029)
    Figure 50. Asia-Pacific Hormonal Transdermal Patches Sales Quantity Market Share by Application (2018-2029)
    Figure 51. Asia-Pacific Hormonal Transdermal Patches Sales Quantity Market Share by Region (2018-2029)
    Figure 52. Asia-Pacific Hormonal Transdermal Patches Consumption Value Market Share by Region (2018-2029)
    Figure 53. China Hormonal Transdermal Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 54. Japan Hormonal Transdermal Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 55. Korea Hormonal Transdermal Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 56. India Hormonal Transdermal Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 57. Southeast Asia Hormonal Transdermal Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 58. Australia Hormonal Transdermal Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 59. South America Hormonal Transdermal Patches Sales Quantity Market Share by Type (2018-2029)
    Figure 60. South America Hormonal Transdermal Patches Sales Quantity Market Share by Application (2018-2029)
    Figure 61. South America Hormonal Transdermal Patches Sales Quantity Market Share by Country (2018-2029)
    Figure 62. South America Hormonal Transdermal Patches Consumption Value Market Share by Country (2018-2029)
    Figure 63. Brazil Hormonal Transdermal Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 64. Argentina Hormonal Transdermal Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 65. Middle East & Africa Hormonal Transdermal Patches Sales Quantity Market Share by Type (2018-2029)
    Figure 66. Middle East & Africa Hormonal Transdermal Patches Sales Quantity Market Share by Application (2018-2029)
    Figure 67. Middle East & Africa Hormonal Transdermal Patches Sales Quantity Market Share by Region (2018-2029)
    Figure 68. Middle East & Africa Hormonal Transdermal Patches Consumption Value Market Share by Region (2018-2029)
    Figure 69. Turkey Hormonal Transdermal Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 70. Egypt Hormonal Transdermal Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 71. Saudi Arabia Hormonal Transdermal Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 72. South Africa Hormonal Transdermal Patches Consumption Value and Growth Rate (2018-2029) & (USD Million)
    Figure 73. Hormonal Transdermal Patches Market Drivers
    Figure 74. Hormonal Transdermal Patches Market Restraints
    Figure 75. Hormonal Transdermal Patches Market Trends
    Figure 76. Porters Five Forces Analysis
    Figure 77. Manufacturing Cost Structure Analysis of Hormonal Transdermal Patches in 2022
    Figure 78. Manufacturing Process Analysis of Hormonal Transdermal Patches
    Figure 79. Hormonal Transdermal Patches Industrial Chain
    Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
    Figure 81. Direct Channel Pros & Cons
    Figure 82. Indirect Channel Pros & Cons
    Figure 83. Methodology
    Figure 84. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Xulane
Twirla
Planned Parenthood
Lvye Pharma
Novartis
Bayer Healthcare Pharmaceuticals
Watson Labs
Women First Healthcare Inc
Noven
AbbVie
Lumara Health
ANI Pharmaceuticals

Related Reports

Global Hormonal Transdermal Patches Supply, Demand and Key Producers, 2023-2029

Global Hormonal Transdermal Patches Supply, Demand and Key Producers, 2023-2029

date 21 Jan 2023

date Medical Devices & Consumables

The global Hormonal Transdermal Patches market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Hormonal Transdermal Patches Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Hormonal Transdermal Patches Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Hormonal Transdermal Patches market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Product Tags

Hormonal Transdermal Patches

Blood Plasma Refrigerator

ENT Camera System

Medical Repair Titanium Mesh

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>